Pioglitazone in Alzheimer's disease: Rationale and clinical trial design

被引：1
|
作者：
Geldmacher, DS
Landreth, GE
机构：
[1] Univ Virginia, Charlottesville, VA USA
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80709-7
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S211 / S212
页数：2
相关论文
共 50 条
  • [1] Dimethyl Fumarate as Potential Treatment for Alzheimer's Disease: Rationale and Clinical Trial Design
    Sharkus, Robert
    Thakkar, Richa
    Kolson, Dennis L.
    Constantinescu, Cris S.
    [J]. BIOMEDICINES, 2023, 11 (05)
  • [2] The Antipsychotic Discontinuation in Alzheimer Disease Trial: Clinical Rationale and Study Design
    Devanand, D. P.
    Mintzer, Jacob
    Schultz, Susan
    Sultzer, David
    de la Pena, Danilo
    Gupta, Sanjay
    Colon, Sylvia
    Schimming, Corbett
    Pelton, Gregory H.
    Andrews, Howard
    Levin, Bruce
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2012, 20 (04): : 362 - 373
  • [3] Treatment of moderate to severe Alzheimer's disease: Rationale and trial design
    Herrmann, Nathan
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2007, 34 : S103 - S108
  • [4] A multicentre randomized clinical trial of physical exercise in Alzheimer's disease (AD): rationale and design of the ADEX study
    Hasselbalch, S. G.
    Hoffmann, K.
    Frederiksen, K. S.
    Sobol, N. A.
    Beyer, N.
    Vogel, A.
    Simonsen, A. H.
    Waldemar, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 95 - 95
  • [5] The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial
    Kehoe, Patrick G.
    Blair, Peter S.
    Howden, Beth
    Thomas, David L.
    Malone, Ian B.
    Horwood, Jeremy
    Clement, Clare
    Selman, Lucy E.
    Baber, Hannah
    Lane, Athene
    Coulthard, Elizabeth
    Passmore, Anthony Peter
    Fox, Nick C.
    Wilkinson, Ian B.
    Ben-Shlomo, Yoav
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (02) : 803 - 814
  • [6] A Novel Subject Synchronization Clinical Trial Design for Alzheimer's Disease
    Schultz, Timothy
    Yang, Eric
    Farnum, Michael
    Lobanov, Victor
    Verbeeck, Rudi
    Raghavan, Nandini
    Samtani, Mahesh N.
    Novak, Gerald
    Shi, Yingqi
    Narayan, Vaibhav
    DiBernardo, Allitia
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (03) : 507 - 516
  • [7] A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
    Geldmacher, David S.
    Fritsch, Thomas
    McClendon, McKee J.
    Landreth, Gary
    [J]. ARCHIVES OF NEUROLOGY, 2011, 68 (01) : 45 - 50
  • [8] Reassessment of Pioglitazone for Alzheimer's Disease
    Saunders, Ann M.
    Burns, Daniel K.
    Gottschalk, William Kirby
    [J]. FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [9] Pioglitazone for the treatment of Alzheimer's disease
    Galimberti, Daniela
    Scarpini, Elio
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (01) : 97 - 101
  • [10] Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study design
    Devanand, D. P.
    Strickler, Jesse G.
    Huey, Edward D.
    Crocco, Elizabeth
    Forester, Brent P.
    Husain, Mustafa M.
    Vahia, Ipsit V.
    Andrews, Howard
    Wall, Melanie M.
    Pelton, Gregory H.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2018, 71 : 33 - 39
12345